Edgardo S. Santos

Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline

Bryan J. Schneider, Nofisat Ismaila, Joachim G.J.V. Aerts et al. · Journal of Clinical Oncology · 2019 · 193 citations

Medicine, Oncology, Radiation Oncology +17

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

Taofeek K. Owonikoko, Huifeng Niu, Kristiaan Nackaerts et al. · Journal of Thoracic Oncology · 2019 · 147 citations · Full text

Medicine, Oncology, Pharmacology +16

Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC)

Luis E. Raez, Kayla Brice, Katerine Dumais et al. · Clinical Lung Cancer · 2022 · 105 citations

Medicine, Oncology, Pathology +16

Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature

Edgardo S. Santos, Leopoldo Arosemena, Luis E. Raez et al. · Liver International · 2006 · 65 citations

Life Sciences, Hematology, Immunology +17

Inhibitor of Differentiation-1 Sustains Mutant <i>KRAS</i> -Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network

Marta Román, Inés López, Elizabeth Guruceaga et al. · Cancer Research · 2018 · 39 citations

Medicine, Molecular Biology, Oncology +17